Screener
Elevance Health ELV Corporate & Other — Premiums
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elevance Health in its filing.
Tagged under the XBRL concept us-gaap:PremiumsEarnedNet.
The source filing: Elevance Health’s 10-Q, filed July 15, 2026.
- Filed
- Jul 15, 2026, 11:27 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001156039-26-000060
| Three Months Ended June 30, 2026 | Health Benefits / Three Months Ended June 30, 2026 | Carelon / Carelon Rx | Carelon / Carelon Services | Carelon / Total | Corporate & Other | Eliminations | Total |
|---|---|---|---|---|---|---|---|
| Premiums | $40,647 | — | $833 | $833 | — | $(201) | $41,279 |
| Product revenue | — | 6,264 | — | 6,264 | — | — | 6,264 |
| Service fees | 2,073 | 3 | 207 | 210 | — | — | 2,283 |
| Operating revenue - unaffiliated | 42,720 | 6,267 | 1,040 | 7,307 | — | (201) | 49,826 |
| Operating revenue - affiliated | — | 4,983 | 6,935 | 11,918 | 6 | (11,924) | — |
| Operating revenue - total | $42,720 | $11,250 | $7,975 | $19,225 | $6 | $(12,125) | $49,826 |
| Benefit expense | $36,739 | — | $6,743 | $6,743 | $6 | $(6,464) | $37,024 |
| Cost of products sold | — | 10,473 | — | 10,473 | — | (4,981) | 5,492 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Elevance Health's corporate & other — premiums?
- Elevance Health (ELV) reported corporate & other — premiums of $0 in Q2 2026.
- What does corporate & other — premiums mean?
- This metric represents the revenue generated from insurance premiums within the corporate and other segment, which typically includes residual or non-core insurance activities. It captures the top-line contribution from insurance products that do not fall into the primary reportable business segments. Tracking this helps identify the scale of secondary or legacy insurance operations.
Ask your AI about Elevance Health's corporate & other — premiums.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude